NKGen Biotech, Inc.

Quarterly Report for period ending 2023-09-30

Quarterly Report for period ending 2023-06-30

Quarterly Report for period ending 2023-03-31

Annual Report for period ending 2022-12-31

Quarterly Report for period ending 2022-09-30

Quarterly Report for period ending 2022-06-30

Quarterly Report for period ending 2022-03-31

Annual Report for period ending 2021-12-31

Quarterly Report for period ending 2021-09-30

Quarterly Report for period ending 2021-09-30

Current report filing

Current report filing

Current report filing

Current report filing

Current report filing

Current report filing

Current report filing

Current report filing

Current report filing

Current report filing

Form for the registration / listing of a class of securities on a national securities exchange pursuant to Section 12(b)

Notification filed by issuer to voluntarily withdraw a class of securities from listing and registration on a national securities exchange

Certification by an exchange approving securities for listing

Notice of Effectiveness

A correspondence can be sent as a document with another submission type or can be sent as a separate submission.

A correspondence can be sent as a document with another submission type or can be sent as a separate submission.

A correspondence can be sent as a document with another submission type or can be sent as a separate submission.

A correspondence can be sent as a document with another submission type or can be sent as a separate submission.

A correspondence can be sent as a document with another submission type or can be sent as a separate submission.

Certification by an exchange approving securities for listing

Scott Kathleen D.: Statement of changes in beneficial ownership of securities

METEORA CAPITAL, LLC: Major Shareholders

Song Paul Y.: Statement of changes in beneficial ownership of securities

Radcliffe Capital Management, L.P.: Major Shareholders

Kim Yong Man: Statement of changes in beneficial ownership of securities

Gagnon Pierre: Statement of changes in beneficial ownership of securities

Klowden Michael: Statement of changes in beneficial ownership of securities

ADAGE CAPITAL PARTNERS GP, L.L.C.: Major Shareholders

NKMAX Co., Ltd.: Major Shareholders

Park Sangwoo: Statement of changes in beneficial ownership of securities

General form of registration statement for all companies including face-amount certificate companies

General form of registration statement for all companies including face-amount certificate companies

General form of registration statement for all companies including face-amount certificate companies

Prospectus filed pursuant to Rule 424(b)(3)

Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Prospectus filed pursuant to Rule 424(b)(3)

Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Definitive proxy statements

Preliminary proxy statement not related to a contested matter or merger/acquisition

Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.

Definitive proxy statements

Preliminary proxy statement not related to a contested matter or merger/acquisition